DE69816796D1 - Pharmazeutische oder nahrungsmittelzusammensetzung für die behandlung von pathologien die assoziiert sind mit einem transplantatabstoss, einer allergischen oder autoimmunreaktion - Google Patents

Pharmazeutische oder nahrungsmittelzusammensetzung für die behandlung von pathologien die assoziiert sind mit einem transplantatabstoss, einer allergischen oder autoimmunreaktion

Info

Publication number
DE69816796D1
DE69816796D1 DE69816796T DE69816796T DE69816796D1 DE 69816796 D1 DE69816796 D1 DE 69816796D1 DE 69816796 T DE69816796 T DE 69816796T DE 69816796 T DE69816796 T DE 69816796T DE 69816796 D1 DE69816796 D1 DE 69816796D1
Authority
DE
Germany
Prior art keywords
allergic
pharmaceutical
food composition
treatment
transplant rejection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69816796T
Other languages
English (en)
Other versions
DE69816796T2 (de
Inventor
Jean Duchateau
Genevieve Servais
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotech Tools SA
Original Assignee
Biotech Tools SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotech Tools SA filed Critical Biotech Tools SA
Application granted granted Critical
Publication of DE69816796D1 publication Critical patent/DE69816796D1/de
Publication of DE69816796T2 publication Critical patent/DE69816796T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69816796T 1997-03-05 1998-03-05 Pharmazeutische oder nahrungsmittelzusammensetzung für die behandlung von pathologien die assoziiert sind mit einem transplantatabstoss, einer allergischen oder autoimmunreaktion Expired - Lifetime DE69816796T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
BE9700199A BE1011033A6 (fr) 1997-03-05 1997-03-05 Composition pharmaceutique et/ou alimentaire pour le traitement de pathologies liees a un rejet de greffe, une reaction allergique ou auto-immune ou du cancer.
BE9700199 1997-03-05
PCT/BE1998/000030 WO1998039029A2 (fr) 1997-03-05 1998-03-05 Composition pharmaceutique ou alimentaire pour le traitement de pathologies liees a un rejet de greffe, une reaction allergique ou auto-immune

Publications (2)

Publication Number Publication Date
DE69816796D1 true DE69816796D1 (de) 2003-09-04
DE69816796T2 DE69816796T2 (de) 2004-05-27

Family

ID=3890389

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69816796T Expired - Lifetime DE69816796T2 (de) 1997-03-05 1998-03-05 Pharmazeutische oder nahrungsmittelzusammensetzung für die behandlung von pathologien die assoziiert sind mit einem transplantatabstoss, einer allergischen oder autoimmunreaktion
DE69841966T Expired - Lifetime DE69841966D1 (de) 1997-03-05 1998-03-05 Pharmazeutische oder Nährungsmittelzusammensetzung für die Behandlung von Pathologien die assoziert sind mit einem Transplantatabstoss

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69841966T Expired - Lifetime DE69841966D1 (de) 1997-03-05 1998-03-05 Pharmazeutische oder Nährungsmittelzusammensetzung für die Behandlung von Pathologien die assoziert sind mit einem Transplantatabstoss

Country Status (10)

Country Link
US (1) US6312711B1 (de)
EP (2) EP0975362B1 (de)
JP (1) JP4554728B2 (de)
AT (2) ATE246003T1 (de)
BE (1) BE1011033A6 (de)
CA (1) CA2283143C (de)
DE (2) DE69816796T2 (de)
DK (2) DK0975362T3 (de)
ES (2) ES2201453T3 (de)
WO (1) WO1998039029A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6709672B2 (en) * 1997-03-05 2004-03-23 Biotech Tools S.A. Pharmaceutical or food composition for treating pathologies associated with graft rejection or an allergic or autoimmune reaction
AU743647B2 (en) 1998-01-31 2002-01-31 Mt. Sinai School Of Medicine Of New York University Methods and reagents for decreasing allergic reactions
US20020012667A1 (en) * 2000-05-16 2002-01-31 Mcmichael John Method for preventing allograft rejection
CA2410903A1 (en) * 2000-06-02 2001-12-06 University Of Connecticut Health Center Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
US20020168376A1 (en) * 2001-02-28 2002-11-14 Michael Babich Compositions of multimeric profilin for diagnosis and treatment of allergies
EP1536829A4 (de) * 2001-08-20 2006-05-31 Univ Connecticut Health Ct Verfahren zur herstellung von zusammensetzungen mit hitzeschock-proteinen oder alpha-2-makroglobulin zur behandlung von krebs und infektionskrankheiten
EP1603391A4 (de) * 2003-02-20 2009-06-24 Univ Connecticut Health Ct Verfahren zur verwendung von zusammensetzungen, umfassend hitzeschockproteine oder alpha-2-macroglobulin bei der behandlung von krebs und infektionskrankheiten
ES2396231T3 (es) * 2003-05-21 2013-02-20 Biotech Tools S.A. Complejo peptídico
EP2316844A3 (de) 2003-05-21 2011-07-20 Biotech Tools S.A. Peptidkomplex
EP1479689A1 (de) * 2003-05-21 2004-11-24 Biotech Tools S.A. Peptidkomplex
DK1641488T3 (da) * 2003-06-23 2011-07-18 Biotech Tools Sa Epitopsammensætning til enterisk administrering fremstillet ved hydrolyse af antigenstrukturer med chymotrypsin
WO2004112833A1 (en) * 2003-06-23 2004-12-29 Biotech Tools Sa Epitope composition for sublingual, buccal or enteric administration prepared by hydrolysis of antigenic structures with chymotrypsin
EP2391229B1 (de) * 2009-01-29 2015-07-15 Alfa Biogene International B.V. "functional food"-produkt, welches ein hitzeschockprotein aus alfalfa oder ein hydrolysat davon enthält
US20140255449A1 (en) 2011-07-21 2014-09-11 Biotech Tools S.A. Dosage of dnak
AU2017341096A1 (en) 2016-10-05 2019-04-04 Asit Biotech S.A. Prevention of allergy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0700445T3 (da) * 1993-06-04 2002-05-13 Whitehead Biomedical Inst Stressproteiner og anvendelser deraf
US5961979A (en) * 1994-03-16 1999-10-05 Mount Sinai School Of Medicine Of The City University Of New York Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
BE1008817A6 (fr) 1994-10-28 1996-08-06 Univ Bruxelles Procede d'obtention d'adn bicatenaire membranaire humain, produit obtenu par ce procede et trousse de diagnostic le contenant.
JP3656277B2 (ja) * 1995-05-17 2005-06-08 味の素株式会社 組換えｄｎａ法によるトランスグルタミナーゼの効率的製造法
BE1009359A7 (fr) 1995-05-19 1997-02-04 Univ Bruxelles Procede de detection et/ou de quantification de ligands specifiques d'une pathologie liee a une reponse allergique.
EP0888053A4 (de) * 1995-08-18 2002-07-31 Sloan Kettering Inst Cancer Verfahren zur behandlung von krebs und infektionskrankheiten und dafür verwendbare zusammensetzungen
EP0941315B1 (de) * 1996-11-26 2006-03-01 Stressgen Biotechnologies Corporation Fusionsproteine, die stressproteine beinhalten, zum hervorrufen einer immunantwort
US6017540A (en) * 1997-02-07 2000-01-25 Fordham University Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes

Also Published As

Publication number Publication date
EP1354599A2 (de) 2003-10-22
DK1354599T3 (da) 2011-02-07
EP1354599B1 (de) 2010-10-20
JP4554728B2 (ja) 2010-09-29
DE69816796T2 (de) 2004-05-27
EP1354599A3 (de) 2003-12-10
US6312711B1 (en) 2001-11-06
DE69841966D1 (de) 2010-12-02
BE1011033A6 (fr) 1999-04-06
ATE246003T1 (de) 2003-08-15
WO1998039029A3 (fr) 1999-01-14
WO1998039029A2 (fr) 1998-09-11
EP0975362B1 (de) 2003-07-30
ES2201453T3 (es) 2004-03-16
JP2001514623A (ja) 2001-09-11
ES2354941T3 (es) 2011-03-21
CA2283143C (fr) 2014-05-27
EP0975362A2 (de) 2000-02-02
DK0975362T3 (da) 2003-11-10
ATE485054T1 (de) 2010-11-15
CA2283143A1 (fr) 1998-09-11

Similar Documents

Publication Publication Date Title
DE69816796D1 (de) Pharmazeutische oder nahrungsmittelzusammensetzung für die behandlung von pathologien die assoziiert sind mit einem transplantatabstoss, einer allergischen oder autoimmunreaktion
DE68903482D1 (de) Zement, verfahren zur herstellung dieses zements und verfahren zur herstellung von produkten mit diesem zement.
DE3485466D1 (de) Schichtkoerper und verfahren zur herstellung desselben.
DE3886760D1 (de) Monoklonale antikörper gegen menschliche interleukin-4 und die sie erzeugenden hybridomen.
DE3879320D1 (de) Copolyester und verfahren zu dessen herstellung.
DE68923129D1 (de) Verpackungselement für Halbleiterbauelement und Verfahren zur Herstellung des Verpackungselementes.
DE3881669D1 (de) Waermeresistenter verbundkoerper und verfahren zu seiner herstellung.
DE3777421D1 (de) Hochfester stahl fuer ventilfedern, verfahren zur herstellung des stahles und daraus hergestellte ventilfedern.
DE68909730D1 (de) Reinigungsverfahren für Wasser enthaltende Behälter und Systeme dafür.
DE68910356D1 (de) Folienkondensator, Verfahren und Vorrichtung für seine Herstellung.
PT946873E (pt) Metodos para diagnostico da aspergilose broncopulmonar alergica
ATA111789A (de) Humaner monoklonaler antikörper und hybridom zur herstellung desselben
DE3786911D1 (de) Ankeranordnung und motorkonstruktion und verfahren zur herstellung derselben.
CA2008817A1 (en) M-csf monoclonal antibodies that recognize a neutralizing conformational epitope
DE3583891D1 (de) Monoklonaler menschlicher anti-igg-koerper und verfahren zu seiner herstellung.
DE68909297D1 (de) Aufbau zur Kurbelwellenunterstützung.
DE3888437D1 (de) Immobilisierte Antikörper.
DE58900581D1 (de) Halter zur fixierung von zumindest einem laenglichen rundkoerper.
NO883603L (no) Humane monoklonale antistoffer og profylaktiske og terapeutiske midler mot infektioese sykdommer inneholdende disse som effektiv bestanddel.
DE68903390D1 (de) Ladungstransferspeicher und verfahren zur herstellung desselben.
DE3785175D1 (de) A-assoziierte h-antigene, spezifische monoklonale antikoerper und methoden zu deren verwendung zur blutgruppenbestimmung.
DE69018027D1 (de) Syndiotaktisches alpha-Olefin-Alkenylsilancopolymer und Verfahren zur Herstellung desselben.
DE68913779D1 (de) D-Amidase und Verfahren zur Herstellung von D-alpha-Alanin und/oder L-alpha-Alaninamid.
NL186181B (nl) Werkwijze voor de hydrogenering van tallolie natuurhars.
DE68906226D1 (de) Verfahren zur herstellung von cyclopenten-, cyclopentan- und cyclohexanderivaten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition